|
|
|
| home > white papers > CRSF Label - Child-Resistant Blister Packs With Booklet Label - Faubel & Co. Nachfolger GmbH |
|
|
 WHITE PAPERS |
|
Faubel & Co. Nachfolger GmbH
|
|
CRSF Label - Child-Resistant Blister Packs With Booklet Label
|
|
This case study explains how Faubel was commissioned by a leading global pharmaceutical company to develop a label for an aluminum blister pack with 14 cavities, which was used as part of a multinational clinical trial. This label was intended to both protect infants from erroneous ingestion and facilitate use by seniors.
The project was primarily focused on the functionality of the packaging solution, including with regard to the integrity of the inner soft capsules. Due to different countries participating in the clinical trial, the objective was to achieve certification according to EU standard DIN 14375 and US standard 16 CFR § 1700.20 with the final concept as well as to accommodate more than 20 different languages. Despite the high requirements in terms of function and the standard, Faubel was anxious to provide an efficient packaging concept.
|
|
|
|
|
|
|
|
 |
News and Press Releases |
 |
Quanticate Partners with CluePoints to Offer Data Quality Oversight capabilities
Quanticate, a data-focused clinical research organisation (CRO), has announced that it has partnered with CluePoints as part of its new Data Quality Oversight service.
More info >> |
|
 |
White Papers |
 |
|
Soothing the Logistical Headache of Clinical Trials
Equilibrium Travel Management
As many as 30 per cent of subjects on phase three clinical studies drop out. Gruelling schedules, high travel costs and time waiting for expense reimbursement can all be factors in these fall rates, and this can be very problematic, delaying or even leading to the cancellation of the trial. It is crucial to keep subjects motivated, and through efficient travel and expense management, this can be achieved.
More info >> |
|
 |
Industry Events |
 |
BIO-Europe 2018-24th Annual International Partnering Conference
5-7 November 2018, Bella Center Copenhagen, Denmark
The 24th annual BIO-Europe® event is the largest biotechnology partnering conference held in Europe. Over 4,000 global decision makers from biotechnology, pharma and finance annually attend BIO-Europe to identify new business opportunities and develop strategic relationships.
Business development executives and dealmakers consider BIO-Europe a must-attend event and an effective business strategy enabling them to meet and present to numerous potential partners. BIO-Europe features the industry’s most advanced web-based partnering system enabling delegates from all parts of the biotechnology value chain to quickly identify, engage and enter into strategic relationships that drive their business successfully forward.
More info >> |
|
|
|
